source
- Recon: FDA approves drugs for four rare diseases; Pfizer signs $2.6B licensing deal in China for in vivo CAR-TWelcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 1d ago↗ source
- Euro Roundup: UK MHRA launches service to support early consideration of good practicesThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has created AdvanceGxP to help companies consider good practice requirements earlier.raps · 1d ago↗ source
- More drugmakers look to standalone medical devices for combo productsBALTIMORE – Drugmakers that want to develop standalone medical devices to be used in combination with their drugs should evaluate the devices’ capabilities and requirements while engaging health au…